Lennon David James, CEO of Whitehawk Therapeutics WHWK, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 05/14.

LJ

LJ

Lennon David James

CEO

Company

Whitehawk Therapeutics WHWK

First filing

23/10/03

Trades

25 trades

Buys / sales

0 / 8

12-month net buying

−$1.1M

Last trade

05/14

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Whitehawk TherapeuticsWHWK	Open-market sale	04/09	04/10	14,500 sh	$3.38	$49,010	−2.7%
Whitehawk TherapeuticsWHWK	Open-market sale	04/06–04/08	04/08	260,427 sh3 trades	$3.45avg.	$899,537.86	−32.8%
Whitehawk TherapeuticsWHWK	Open-market sale	04/02	04/03	26,858 sh	$3.48	$93,465.84	−3.3%
Whitehawk TherapeuticsWHWK	Open-market sale	03/02	03/10	5,100 sh	$3.31	$16,881	−10.3%
Whitehawk TherapeuticsWHWK	Open-market sale	25/03/03	25/03/03	5,690 sh	$2.35	$13,371.5	−14.5%
Whitehawk TherapeuticsWHWK	Open-market sale	24/10/03	24/10/03	9,689 sh	$1.94	$18,796.66	−29.8%